Advanced search

Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
De Rycke, Leen, Isabelle Peene, Elli Kruithof, Ilse Hoffman, Bert Vander Cruyssen, J JURAS, L NUYTINCK, Eric Veys, and Filip De Keyser. 2005. “Mannose-binding Lectin (Mbl2) Polymorphisms in Rheumatoid Arthritis Are Not Associated with Susceptibility, Radiological Progression Rate, or Serological Markers.” In Arthritis and Rheumatism, 52:126. WILEY-LISS.
APA
De Rycke, Leen, Peene, I., Kruithof, E., Hoffman, I., Vander Cruyssen, B., JURAS, J., NUYTINCK, L., et al. (2005). Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers. ARTHRITIS AND RHEUMATISM (Vol. 52, p. 126). WILEY-LISS.
Vancouver
1.
De Rycke L, Peene I, Kruithof E, Hoffman I, Vander Cruyssen B, JURAS J, et al. Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers. ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2005. p. 126.
MLA
De Rycke, Leen, Isabelle Peene, Elli Kruithof, et al. “Mannose-binding Lectin (Mbl2) Polymorphisms in Rheumatoid Arthritis Are Not Associated with Susceptibility, Radiological Progression Rate, or Serological Markers.” Arthritis and Rheumatism. Vol. 52. WILEY-LISS, 2005. 126. Print.
@inproceedings{329404,
  author       = {De Rycke, Leen and Peene, Isabelle and Kruithof, Elli and Hoffman, Ilse and Vander Cruyssen, Bert and JURAS, J and NUYTINCK, L and Veys, Eric and De Keyser, Filip},
  booktitle    = {ARTHRITIS AND RHEUMATISM},
  issn         = {0004-3591},
  language     = {eng},
  number       = {9},
  pages        = {S126-S127},
  publisher    = {WILEY-LISS},
  title        = {Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers},
  volume       = {52},
  year         = {2005},
}

Web of Science
Times cited: